Confluence Investment Management LLC Sells 16,696 Shares of AptarGroup, Inc. $ATR

Confluence Investment Management LLC trimmed its stake in AptarGroup, Inc. (NYSE:ATR) by 10.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 144,239 shares of the industrial products company’s stock after selling 16,696 shares during the period. Confluence Investment Management LLC owned 0.23% of AptarGroup worth $17,476,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the stock. Parkside Financial Bank & Trust raised its position in shares of AptarGroup by 41.9% in the second quarter. Parkside Financial Bank & Trust now owns 298 shares of the industrial products company’s stock valued at $37,000 after purchasing an additional 88 shares during the period. State of Wyoming grew its stake in AptarGroup by 4.5% in the 1st quarter. State of Wyoming now owns 2,252 shares of the industrial products company’s stock valued at $284,000 after buying an additional 98 shares during the last quarter. IFP Advisors Inc lifted its position in AptarGroup by 47.0% during the 4th quarter. IFP Advisors Inc now owns 369 shares of the industrial products company’s stock worth $45,000 after acquiring an additional 118 shares during the last quarter. Hanson & Doremus Investment Management lifted its position in AptarGroup by 0.7% during the 1st quarter. Hanson & Doremus Investment Management now owns 17,632 shares of the industrial products company’s stock worth $2,222,000 after acquiring an additional 130 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its holdings in AptarGroup by 214.1% during the first quarter. Geneos Wealth Management Inc. now owns 201 shares of the industrial products company’s stock valued at $25,000 after acquiring an additional 137 shares during the period. Institutional investors own 88.52% of the company’s stock.

AptarGroup Stock Performance

NYSE ATR traded up $0.04 during midday trading on Thursday, hitting $121.20. The company had a trading volume of 124,978 shares, compared to its average volume of 490,873. The firm has a fifty day simple moving average of $130.03 and a two-hundred day simple moving average of $125.53. AptarGroup, Inc. has a fifty-two week low of $103.23 and a fifty-two week high of $146.91. The company has a quick ratio of 1.10, a current ratio of 1.61 and a debt-to-equity ratio of 0.42. The stock has a market cap of $7.71 billion, a price-to-earnings ratio of 21.92, a P/E/G ratio of 3.15 and a beta of 0.38.

AptarGroup (NYSE:ATR) last announced its quarterly earnings data on Thursday, July 30th. The industrial products company reported $1.42 EPS for the quarter, beating analysts’ consensus estimates of $1.35 by $0.07. AptarGroup had a net margin of 9.22% and a return on equity of 13.31%. The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.01 billion. During the same quarter in the prior year, the business earned $1.66 earnings per share. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. AptarGroup has set its Q3 2026 guidance at 1.450-1.530 EPS. Equities analysts forecast that AptarGroup, Inc. will post 5.48 earnings per share for the current fiscal year.

AptarGroup Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 20th. Stockholders of record on Thursday, July 30th were issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend was Thursday, July 30th. AptarGroup’s dividend payout ratio (DPR) is presently 34.72%.

Insider Transactions at AptarGroup

In related news, CEO Gael Touya sold 3,740 shares of the company’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $133.76, for a total value of $500,262.40. Following the completion of the transaction, the chief executive officer directly owned 29,102 shares in the company, valued at approximately $3,892,683.52. This represents a 11.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Shiela Vinczeller sold 765 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $130.37, for a total value of $99,733.05. Following the completion of the transaction, the insider directly owned 26,313 shares of the company’s stock, valued at approximately $3,430,425.81. This trade represents a 2.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 23,197 shares of company stock valued at $3,134,828. Company insiders own 0.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on ATR. Raymond James Financial reaffirmed an “outperform” rating and issued a $160.00 price target on shares of AptarGroup in a research report on Wednesday, July 15th. Weiss Ratings restated a “hold (c)” rating on shares of AptarGroup in a research note on Monday, September 21st. Wells Fargo & Company raised their target price on AptarGroup from $145.00 to $155.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Finally, Bank of America raised AptarGroup from a “neutral” rating to a “buy” rating and set a $173.00 price target on the stock in a research report on Tuesday, July 14th. Five equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $172.80.

AptarGroup Company Profile

AptarGroup, Inc (NYSE: ATR) is a global company that designs and manufactures dispensing, drug-delivery and packaging solutions. Its products are used by pharmaceutical, consumer health, beauty, personal care, food and beverage companies, helping customers deliver, protect and package a wide range of products.

The company operates through three primary businesses: Aptar Pharma, which develops delivery systems for nasal, inhaled, ophthalmic and other drug applications; Aptar Beauty, which supplies dispensing systems, pumps, sprayers and packaging components for beauty and personal care products; and Aptar Closures, which produces dispensing closures and other packaging systems for food, beverage, personal care and household products.

Aptar serves customers internationally through manufacturing, research and development, and commercial operations across North America, Europe, Asia and other global markets.